Preconception Counseling

Primary Care - Clinics in Office Practice

Volumn 39, Issue 1, 2012, Pages 1-16

  Lanik, Aaron D ^a  

^a Thayer County Health Services   (United States)

Author keywords

Medical history; Preconception counseling; Pregnancy; Reproductive history

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHICKENPOX VACCINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FOLIC ACID; HEPATITIS B VACCINE; HYDROXYPROGESTERONE; ILLICIT DRUG; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TETANUS TOXOID; THIAZIDE DIURETIC AGENT; THYROID HORMONE; THYROTROPIN; VACCINE; ANTIHYPERTENSIVE AGENT;

ALCOHOL CONSUMPTION; CESAREAN SECTION; CHICKENPOX; CHLAMYDIASIS; CIGARETTE SMOKING; CONGENITAL DISORDER; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG USE; FAMILY HISTORY; GONORRHEA; HEPATITIS B; HERBAL MEDICINE; HIGH RISK PREGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHYROIDISM; INFECTION RISK; INFERTILITY; INFLUENZA; INTIMATE PARTNER VIOLENCE; LABORATORY TEST; LOW DRUG DOSE; MATERNAL CARE; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; MEDICAL HISTORY; NEURAL TUBE DEFECT; OBESITY; PARTNER VIOLENCE; PATIENT COUNSELING; PERTUSSIS; PRECONCEPTION COUNSELING; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RUBELLA; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SMOKING CESSATION; SPONTANEOUS ABORTION; SUBCLINICAL HYPOTHYROIDISM; SUPPLEMENTATION; SYPHILIS; SYSTOLIC BLOOD PRESSURE; TERATOGENESIS; TETANUS; VACCINATION; WEIGHT REDUCTION; DIRECTIVE COUNSELING; FEMALE; HYPERTENSION; MATERNAL WELFARE; METHODOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; REPRODUCTIVE HISTORY; RISK ASSESSMENT;

ANTIHYPERTENSIVE AGENTS; DIABETES, GESTATIONAL; DIRECTIVE COUNSELING; FEMALE; HUMANS; HYPERTENSION; MATERNAL WELFARE; OBESITY; PRECONCEPTION CARE; PREGNANCY; PRENATAL CARE; REPRODUCTIVE HISTORY; RISK ASSESSMENT;

EID: 84856570032     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2011.11.001     Document Type: Review

References (64)

1. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295(13):1549-1555.
2. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among United States adults, 1999-2008. JAMA 2010, 303(3):235-241.
3. Davis E., Olson C. Obesity in pregnancy. Prim Care Clin Office Pract 2009, 36(2):341-356.
4. Lee C.Y., Koren G. Maternal obesity: effects on pregnancy and the role of pre-conception counseling. JObstet Gynecol 2010, 30(2):101-106.
5. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42(6):1206-1252.
6. ACOG Committee on Practice Bulletins ACOG practice bulletin. Chronic hypertension in pregnancy. Obstet Gynecol 2001, 98(Suppl 1):177-185.
7. Magee L.A., Schick B., Donnenfeld A.E., et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996, 174(3):823-828.
8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183:S1-S22.
9. Reece E.A., Homko C.J. Prepregnancy care and the prevention of fetal malformation in the pregnancy complicated by diabetes. Clin Obstet Gynecol 2007, 50(4):990-997.
10. ACOG Committee on Practice Bulletins ACOG practice bulletin. Pregestational diabetes mellitus. Obstet Gynecol 2005, 105(3):675-685.
11. American Diabetes Association Preconception care of women with diabetes. Diabetes Care 2005, 27(Suppl 1):S76-S78.
12. Pratt L.A., Brody D.J. Depression in the United States household population, 2005-2006. NCHS Data Brief 2008, (7):1-8.
13. Marcus S.C., Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry 2010, 67(12):1265-1273.
14. Yonkers K.A., Wisner K.L., Stewart D.E., et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol 2009, 114(3):703-713.
15. Fitzpatrick D.L., Russell M.A. Diagnosis and management of thyroid disease in pregnancy. Obstet Gynecol Clin N Am 2010, 37(2):173-193.
16. Davis L.E., Leveno K.J., Cunningham F.G. Hypothyroidism complicating pregnancy. Obstet Gynecol 1988, 72(1):108-112.
17. ACOG Committee on Practice Bulletins ACOG practice bulletin. Thyroid disease in pregnancy. Obstet Gynecol 2002, 100(2):387-396.
18. Gyamfi C., Wapner R.J., D'Alton M.E. Thyroid dysfunction in pregnancy. Obstet Gynecol 2009, 133(3):702-707.
19. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2007. Natl Vital Stat Rep 2010, 58(27):1-85.
20. Mercer M.M., Goldenberg R.L., Moawad A.H., et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1999, 185(5):1216-1221.
21. Adams M.M., Elam-Evans L.D., Wilson H.G., et al. Rates of and factors associated with recurrence of preterm delivery. JAMA 2000, 283(12):1591-1596.
22. Dodd J.M., Flenady V., Cincotta R., et al. Prenatal administration of progesterone forpreventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2006, 1. CD004947. doi:10.1002/14651858.CD004947.pub2.
23. American College of Obstetricians and Gynecologists Use of progesterone toreduce preterm birth, ACOG Committee Opinion No. 419, October 2008 (replaces No. 291, November 2003). Obstet Gynecol 2008, 112(4):963-965.
24. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. NEngl J Med 2003, 348:2379-2385. [published erratum appears in N Engl J Med 2003;349:1299].
25. Hernandez-Diaz S., Toh S., Cnattingius S. Risk of pre-eclampsia In first and subsequent pregnancies: prospective cohort study. BMJ 2009, 338:b2255.
26. Barton J.R., Sibai B.M. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008, 112(2):359-372.
27. Gujold E., Roberge S., Lacasse Y., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010, 116(2):402-414.
28. ACOG Committee on Practice Bulletins ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia, number 33, January 2002. Obstet Gynecol 2002, 99(1):159-167.
29. Stirrat G.M. Recurrent miscarriage I: definition and epidemiology. Lancet 1990, 336:673-675.
30. Stephenson M., Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol 2007, 50(1):132-145.
31. ACOG Committee on Practice Bulletins ACOG practice bulletin. Management of recurrent pregnancy loss, number 24, February 2001 (replaces technical bulletin number 212, September 1995). Int J Gynaecol Obstet 2002, 78(2):179-190.
32. American Society of Reproductive Medicine Practice Committee Definitions of infertility and recurrent pregnancy loss. Fertil Steril 2008, 90(Suppl 5):S60.
33. Frey K.A., Patel K.S. Initial evaluation and management of infertility by the primary care physician. Mayo Clin Proc 2004, 79(11):1439-1443.
34. Centers for Disease Control and Prevention Vital signs: current cigarette smoking among adults aged ≥18 years-United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(35):1135-1140.
35. Einarson A., Riordan S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol 2009, 65:325-330.
36. United States Preventive Services Task Force Counseling and interventions to prevent tobacco use and tobacco caused disease in adults and pregnant women: United States Preventive Services Task Force Reaffirmation Recommendation Statement. Ann Intern Med 2009, 150:551-555.
37. American College of Obstetricians and Gynecologists Smoking cessation during pregnancy, ACOG Committee Opinion No. 316. Obstet Gynecol 2005, 106(4):883-888.
38. Muhuri P.K., Gfroerer J.C. Substance use among women: associations with pregnancy, parenting, and race/ethnicity. Matern Child Health J 2009, 13:376-385.
39. Wattendorf D.J., Muenke M. Fetal alcohol spectrum disorders. Am Fam Physician 2005, 72(2):279-282.
40. May P.A., Gossage J.P. Estimating the prevalence of fetal alcohol syndrome. Alcohol Res Health 2001, 25(3):159-167.
41. Substance Abuse and Mental Health Services Administration Results from the 2009 National Survey on Drug Use and Health: Volume I 2010, Summary of national findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586 Findings), Substance Abuse and Mental Health Services Administration, Rockville (MD).
42. Floyd R.L., Jack B.W., Cefalo R., et al. The clinical content of preconception care:alcohol, tobacco, and illicit drug exposures. Am J Obstet Gynecol 2008, 199(6 Suppl 2):S333-S339.
43. Centers for Disease Control and Prevention Sexually transmitted disease surveillance 2009 2010, US Department of Health and Human Services, Atlanta (GA).
44. Centers for Disease Control and Prevention. HIV surveillance report, 2009; vol. 21. Available at: Published February 2011. Accessed March 15, 2011. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/.
45. Majeroni B.A., Ukkadam S. Screening and treatment for sexually transmitted infections in pregnancy. Am Fam Physician 2007, 76(2):265-270.
46. Genc M., Ledger W.J. Syphilis in pregnancy. Sex Transm Infect 2000, 76:73-79.
47. Volmink J., Siegfried N.L., van der Merwe L., et al. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2007, 1. CD003510.
48. Meyers D., Wolff T., Gregory K., et al. USPSTF recommendations for STI screening. Am Fam Physician 2008, 77(6):819-824.
49. Chu S.Y., Goodwin M.M., D'Angelo D.V. Physical violence against U.S. women around the time of pregnancy, 2004-2007. Am J Prev Med 2010, 38(3):317-322.
50. Chambliss L.R. Intimate partner violence and its implication for pregnancy. Clin Obstet Gynecol 2008, 81(2):385-397.
51. Sarkar N.N. The impact of intimate partner violence on women's reproductive health and pregnancy outcome. JObstet Gynecol 2008, 28(3):266-271.
52. United States Preventative Services Task Force Screening for family and intimate partner violence: recommendation statement. Ann Fam Med 2004, 2(2):156-160.
53. American College of Obstetricians and Gynecologists Psychosocial risk factors: perinatal screening and intervention, ACOG Committee Opinion No. 343. Obstet Gynecol 2006, 108(2):469-477.
54. American Academy of Family Physicians. Policy on family and intimate partner violence and abuse. Available at: Accessed March 12, 2011. http://www.aafp.org/online/en/home/policy/policies/f/familyandintimatepartner-violenceandabuse.html.
55. American Academy of Pediatrics, Committee on Child Abuse and Neglect The role of the pediatrician in recognizing and intervening on behalf of abused women. Pediatrics 1998, 101:1091-1092.
56. American Medical Association Diagnostic and treatment guidelines on domestic violence. Arch Fam Med 1992, 1(1):39-47.
57. Mehta N., Larson L. Pharmacotherapy in pregnancy and lactation. Clin Chest Med 2011, 32(1):43-52.
58. US Food and Drug Administration. Dietary supplements. Available at: Accessed March 15, 2011. http://www.fda.gov/Food/DietarySupplements/default.htm.
59. ACOG Committee on Practice Bulletins ACOG practice bulletin. Neural tube defects, number 44, July 2003. Obstet Gynecol 2003, 102(1):203-213.
60. Centers for Disease Control and Prevention Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR 2010, 59(No. RR-8):32-37.
61. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR 2011, 60(No. RR-1):13-15.
62. Centers for Disease Control and Prevention Acomprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR 2005, 54(No. RR-16):12-14.
63. Centers for Disease Control and Prevention Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998, 47(No. RR-8):32-33.
64. Centers for Disease Control and Prevention Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(No. RR-4):16-17. 24-6.